The AI training programme that pharma professionals consistently say is the only one built for the world they actually work in
Live training, custom programmes, and on-demand resources — all built exclusively around biopharmaceutical commercial reality
Why pharma professionals who attend leave with something they can use immediately
Most pharma professionals who attend AI training elsewhere leave with a general understanding of AI that requires significant translation before it becomes useful in their specific role. They know what machine learning is. They understand large language models in theory. But they cannot connect that knowledge to the commercial decisions, regulatory constraints, and operational realities they face every day.
This training is different because it never leaves the pharmaceutical context. Every concept is explained through pharma examples. Every framework is built for pharma challenges. Every session is led by someone who has spent over two decades implementing AI inside the organisations attendees work in.
The specific problem this training is designed to solve
The challenge facing most pharma professionals is not a lack of AI tools — it is a lack of the strategic framework to know which tools matter, which AI initiatives are worth pursuing, and how to connect AI capability to the commercial decisions that actually determine performance.
Without that framework, teams accumulate AI knowledge that does not compound into results. They attend generic courses, follow industry news, and still cannot answer the question their leadership is asking: what should we actually do, and where do we start?
What attendees consistently say changes after this training
Attendees consistently report the same shift after completing this training: they move from feeling uncertain about AI — unsure what to trust, what to prioritise, and how to lead AI conversations confidently — to having a clear, workable framework they can apply to their specific role and challenges from the day they return to work.
That shift is not theoretical. It is reflected in the feedback from every cohort we have run — and it is the reason the pharma organisations that send one team member typically send more.
"Dr. Bates is the best translator of AI for Healthcare commercial teams so that the translation allows for a strong collaborative partnership with tech vendors and data science teams. Something that was difficult to achieve in the past."
What every attendee gains — regardless of their function or seniority
Every attendee — regardless of function, seniority, or prior AI knowledge — leaves with:
- A clear understanding of how AI applies to their specific role — explained in pharmaceutical commercial language, not data science terminology
- Practical experience using AI tools that are relevant and compliant within pharma’s regulatory environment
- The prompting skills to get genuinely useful outputs from large language models for their day-to-day work
- A personal AI opportunity map — identifying the highest-value AI applications for their specific function and challenges
- The ability to navigate AI compliance and governance requirements specific to pharmaceutical organisations
Three formats — choose the one that fits your team's needs and timeline
Three formats — choose the one that fits your team's needs and timeline
Each format is described in full below. Most organisations begin with the two-day masterclass for senior leaders and follow with custom programmes for broader teams.
One-day AI foundations training for pharma teams
A focused one-day programme covering the essential AI foundations every pharma professional needs — regardless of function or prior technical knowledge
Designed for teams that need a shared AI foundation — a common language and framework that allows everyone from commercial leads to medical affairs professionals to contribute to AI strategy conversations with confidence
What the one-day programme covers:
- AI and Generative AI fundamentals — explained in pharma commercial language, not technical jargon
- Practical applications specific to each pharma business unit and function
- How AI projects are structured, what makes them succeed, and what most commonly causes them to fail
- Legal, compliance, and ethical requirements specific to pharmaceutical AI — including privacy, regulatory, and promotional considerations
- Hands-on experience with AI tools that are both powerful and compliant within pharma’s operating environment
- Prompting skills — how to get genuinely useful outputs from large language models for your specific pharma role
- A personal action plan — the specific AI opportunities most relevant to your function that you can begin pursuing immediately
Best suited for: Teams who need a shared AI foundation quickly — particularly organisations running the one-day programme as a precursor to the two-day masterclass for leadership teams
Upcoming one-day sessions are announced on a rolling basis. Register your interest below to be notified when new dates are released in your region.
LONDON
NEW YORK
BASEL
DUBAI
SAN FRANCISCO
Sydney
Two-day AI strategy masterclass for pharma leaders
The complete AI strategy programme for pharmaceutical professionals — built around your commercial reality, not generic frameworks
Designed for pharmaceutical leaders who need to move beyond AI awareness into confident strategic application — with a plan they can begin executing the week they return
Day 1: AI foundations in pharmaceutical context
- AI and Generative AI explained for non-technical pharma professionals — without coding, without data science theory
- How AI is currently being applied across drug discovery, R&D, regulatory, medical affairs, market access, and commercial operations — with real case examples from each function
- The AI landscape specific to pharma — which tools, platforms, and approaches are most relevant, which are overhyped, and which represent genuine commercial opportunity
- Legal, compliance, and ethical requirements for AI in pharmaceutical organisations — what you need to know to use AI responsibly and compliantly
- Hands-on prompting workshops — learning to get genuinely useful outputs from large language models for pharma-specific tasks
Day 2: Building your pharma AI strategy
- AI use case identification and prioritisation — mapped to your specific commercial challenges and highest-ROI opportunities
- Stakeholder analysis and solution design — ensuring AI initiatives have the organisational buy-in they need to succeed
- Data strategy — identifying what data you need, where to source it, and how to use it compliantly
- Technology selection — evaluating and choosing the right AI tools and platforms for your specific needs without vendor bias
- ROI modelling — building the financial case for your AI initiatives in language your finance function and board will accept
- Business case development workshop — leaving with a draft business case for your highest-priority AI initiative
- Implementation planning — a concrete 90-day action plan your team can begin executing immediately
- The AI horizon — what is coming in pharmaceutical AI over the next 12 to 18 months, what it means for your organisation, and what to do now to stay ahead
Best suited for: Senior pharmaceutical leaders and their teams who are ready to move from AI awareness to a concrete, executable AI strategy for their organisation
From AI uncertainty to strategic confidence — in two days
The next masterclass cohorts are being scheduled now for London, NEW YORK, Basel, DUBAI, SAN FRANCISCO and Sydney. Places are limited to maintain the quality of the learning environment.
Register your interest below to be notified when your preferred location is announced — and to be offered priority booking before public release.
The two-day masterclass is designed to meet attendees where they are — whether they are approaching AI for the first time, building on existing knowledge, or looking to formalise and deepen a strategic framework they have been developing independently. Every session is calibrated to deliver genuine new insight regardless of starting point.
The experience and track record behind every session
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Every session of the Eularis masterclass draws directly from over two decades of pharmaceutical AI implementation — not from academic research or generic business frameworks, but from the accumulated experience of building, deploying, and measuring AI strategy inside the organisations attendees work in. That experience includes:
- Over 1,000 pharmaceutical AI strategies and implementations delivered across top 20 global pharma organisations
- Direct work across every function of the pharmaceutical value chain — from drug discovery and R&D through regulatory, medical affairs, market access, and commercial operations
- A track record of measurable commercial results — 100% of drug launches supported have become top brands within year one, and an average of 29% growth achieved for established brands
Custom AI training designed around your organisation's specific challenges
Why most organisations that run the open masterclass come back for a custom programme
The open enrolment masterclass delivers exceptional results for individuals and small groups. But when an entire team or business unit needs to develop AI capability together — with training built around their specific therapeutic areas, their specific commercial challenges, and their specific organisational context — a custom programme consistently delivers faster and more sustained results.
The reason is straightforward: when every example, every case study, and every framework in the training is drawn from the attendees’ own world, the knowledge does not need to be translated before it can be applied. It is immediately actionable.
What makes custom training different from the open masterclass
Every custom Eularis training programme is built from scratch around four dimensions of your organisation’s specific context:
- Your therapeutic areas and pipeline — so every AI application discussed is directly relevant to the science and commercial dynamics your team navigates daily
- Your function and value chain position — whether the audience is primarily commercial, medical, regulatory, market access, or cross-functional
- Your current AI maturity — calibrated to meet the team where they are rather than teaching what they already know or losing those newer to the subject
- Your strategic priorities — ensuring the frameworks and tools taught align directly with the AI initiatives your organisation is actually planning or running
What every custom Eularis training programme includes
Every custom Eularis training programme includes:
✓ Pre-training consultation — a structured conversation with the Eularis team to understand your specific challenges, strategic priorities, team composition, and current AI maturity before a single session is designed
✓ Fully customised curriculum — every session, every example, and every framework built around your therapeutic areas, your commercial context, and your team’s specific learning objectives
✓ Comprehensive participant workbooks — take-home reference materials customised to your organisation’s use cases, designed to be used in the weeks and months after training
✓ Curated AI tools — a selection of AI tools relevant and compliant for your specific functions, with hands-on experience built into the programme
✓Private collaboration workspace — a dedicated digital environment for your team to continue learning, sharing, and applying what they have learned after the training day
✓ Implementation-ready frameworks — commercially proven strategic frameworks with financial modelling templates your team can apply directly to your organisation’s AI prioritisation process
✓ 30 days of post-training support — direct email access to the Eularis team for questions, challenges, and guidance as your team begins implementing what they have learned
Interested in a custom programme for your organisation?
The first step is a focused 30-minute conversation with the Eularis team — covering your team’s current AI maturity, your specific commercial challenges, and what a custom programme would look like in practice. There is no obligation and no sales process — just a direct conversation to determine whether a custom engagement is the right fit.
The Eularis training methodology has been refined across over two decades of pharmaceutical AI strategy work — which means everything taught has been tested against the commercial, regulatory, and organisational realities your team faces. The frameworks are not theoretical constructs. They are the same strategic tools Eularis uses with board-level pharma clients globally.
AI is not a silver bullet for all challenges
AI will not solve every pharmaceutical challenge. It will not replace genuine scientific innovation, compensate for a weak pipeline, or deliver market access in markets where the clinical evidence is insufficient. And it will not produce results when it is applied without strategic discipline — which is why 85% of pharma AI projects fail to deliver the return anticipated.
What AI does exceptionally well — when applied strategically to the right decisions — is sharpen the quality of those decisions, accelerate the speed at which they can be made, and reduce the margin for error in execution. That is the specific and valuable thing this training teaches: not what AI can theoretically do, but where and how it actually delivers in pharmaceutical commercial reality.
Cohort sizes are deliberately kept small to ensure every session remains focused, interactive, and directly relevant to the specific challenges and contexts represented in the room. Places are limited and are typically filled in advance of public announcement through our network and returning organisation contacts.
If you are considering attending, registering your interest early is the most reliable way to secure a place in your preferred location.
The track record behind the training
Eularis has delivered over 1,000 pharmaceutical AI strategies and implementations — including more than 300 end-to-end AI builds — for top 20 global pharma organisations across six continents. The training Dr. Bates delivers is drawn directly from that implementation experience. Every framework taught, every case study shared, and every tool demonstrated has been used in real pharmaceutical commercial environments and measured against real commercial outcomes.
The commercial challenges this training equips you to address with AI:
The training equips pharma professionals to apply AI to their most commercially significant challenges — including:
Drug launch optimisation — using AI to identify the highest-value HCP targets, personalise engagement at scale, and maximise revenue from day one
Patent cliff navigation — building AI-driven strategies that protect and replace revenue before, during, and after exclusivity loss
Earlier patient identification — finding diagnosed and undiagnosed patient populations faster and more accurately across rare and common disease areas
Market access acceleration — using AI to strengthen payer evidence, improve account strategy, and reduce time to reimbursement
Medical affairs efficiency — applying AI to evidence synthesis, literature review, and HCP engagement to free scientific staff for higher-value work
Supply chain optimisation — reducing forecasting errors and improving demand planning through AI-driven analytics
R&D acceleration — identifying where AI can compress timelines in drug discovery, clinical trial design, and regulatory submission
These are not theoretical possibilities. They are outcomes Eularis has delivered for pharmaceutical clients across these challenge areas — which is why the training teaches not just what AI can do, but specifically how to apply it to produce results in each of these contexts.
Proof that the approach works
This training is right for you if:
- Your commercial results have not yet reflected the AI investment your organisation has made
- You need a clear framework for identifying which AI initiatives are worth pursuing — and which are not
- You are facing loss of exclusivity (LOE) pressure and need AI strategies that protect and replace revenue
- You want to lead AI conversations in your organisation with confidence — commissioning the right work, challenging the right assumptions, and measuring the right outcomes
- You are ready to move from AI awareness to AI application — with a plan you can begin executing immediately
The authority behind the training — Dr. Andrée Bates
Every session of every Eularis training programme is led personally by Dr. Bates — not delegated to a junior team or delivered by a trainer following a script someone else wrote.
Dr. Andrée Bates founded Eularis in 2003 — at a time when applying artificial intelligence to pharmaceutical commercial strategy was considered by most of the industry to be either premature or irrelevant. Thirty years in pharmaceuticals and over two decades dedicated exclusively to pharma AI strategy have produced a depth of expertise that no generalist trainer or recently converted AI consultant can replicate.
She has personally overseen more than 1,000 pharmaceutical AI engagements across clinical development, medical affairs, market access, and commercial operations — in organisations across North America, Europe, Japan, and Asia Pacific. She has lectured on pharmaceutical AI and healthcare innovation at INSEAD, Henley Business School, Fordham University’s Gabelli School of Business, Northwestern University, and Northeastern University.
Her clients have included organisations across the top 20 global pharmaceutical companies — Novartis, Boehringer Ingelheim, Pfizer, Merck, Novo Nordisk, Takeda, Ferring, and others — and her work has consistently produced measurable commercial outcomes: drug launches that outperform, brands that grow, and organisations that lead rather than follow on AI.
When attendees complete an Eularis training programme, they are not receiving a distillation of academic research or industry reports. They are receiving the accumulated strategic intelligence of someone who has spent longer than anyone else building AI capability inside the world’s leading pharmaceutical organisations.
What every attendee receives in addition to the training itself
Every attendee also receives:
- Pharma AI Strategy Forum access — membership of a private community of pharmaceutical leaders using AI strategically, with ongoing Q&A, peer discussion, and access to Dr. Bates for questions between sessions
- Pharma-specific LLM prompt guides — a comprehensive set of prompt frameworks designed specifically for pharmaceutical commercial, medical, regulatory, and market access applications — immediately usable with any large language model
- Webinar recording library — access to recordings of Dr. Bates’ most relevant presentations on pharmaceutical AI strategy, providing additional context and perspective beyond the live training days
- Preferential access to Eularis on-demand training — a 10% reduction on any Eularis online courses, allowing attendees to continue developing their AI capability after the masterclass at a reduced investment
"The firm we hired previously went a mile wide and an inch deep, but Eularis goes 10 meters wide and a mile deep."
Secure your place on the next masterclass
Places are limited in each cohort to maintain the quality and focus of every session. The most reliable way to secure a place in your preferred location is to register early.
For organisations whose procurement process requires invoice rather than direct payment, Eularis accepts purchase orders — contact us directly to arrange this before booking.
Contact us about invoicing → Fill in the Contact Us Form Here
Trusted by leading pharmaceutical organisations globally
Frequently asked questions about the masterclass
The most common questions we receive before registration are answered below. If your question is not covered, contact us directly — we respond to all enquiries promptly.
If you don’t find an answer to your question here, please get in touch as we’re always happy to help.
This masterclass is designed for pharmaceutical professionals across all functions and seniority levels who need strategic AI fluency — including:
- Senior commercial, medical, market access, and regulatory leaders who need to understand AI well enough to commission it, challenge it, and lead organisations that use it
- Brand directors, business unit leaders, and team managers who are accountable for results in an environment where AI is increasingly determining competitive position
- Professionals who have attended generic AI training and found it insufficiently relevant to their pharmaceutical context
- Executives preparing for board or leadership conversations about AI strategy who need a credible, commercially grounded foundation
Investment varies depending on the format — one-day, two-day, or custom — and the number of participants. Contact us directly for a prompt response with pricing for your specific requirements.
Request pricing by Filling in the Contact Us Form→
Every Eularis masterclass is designed to deliver specific, immediately applicable knowledge and frameworks — not theoretical concepts that require extensive translation before they become useful. If you do not leave with a clear understanding of how AI applies to your specific role and a concrete plan for applying it, contact us and we will work with you directly to address any gaps.
Three things consistently distinguish Eularis from every other AI training provider in pharma.
First, genuine pharmaceutical specificity — everything taught has been built for pharma, not adapted from another industry. There is no translation required.
Second, implementation depth — Dr. Bates has personally overseen over 1,000 pharmaceutical AI strategies and implementations. The training reflects that implementation reality, not academic research or industry reports.
Third, longevity — Eularis has been building pharmaceutical AI strategy since 2003, before most current providers existed. That 20-year head start produces a depth of pattern recognition and contextual understanding that cannot be accelerated.
The masterclass requires full payment at the time of booking. For organisations whose procurement process requires purchase order and invoice rather than direct payment, contact us before booking and we will arrange this promptly.
The booking link takes you to a credit card payment. If your company policy does not allow this, you can raise a PO and we can invoice you. Just let us know if you need that option.